| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123753 | European Journal of Cancer | 2009 | 8 Pages |
Abstract
Cdc2 and caspase 3 could be identified as independent prognostic markers in stage UICC II CCA. They might be of value to select patients who should receive adjuvant treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexander Meyer, Susanne Merkel, Wolfgang Brückl, Vera Schellerer, Claus Schildberg, Valentina Campean, Werner Hohenberger, Roland S. Croner,